Search Results 851-860 of 14768 for anti-TNF drugs

  1. A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients with Moderately to Severely Active Crohn's Disease (UNITI-2) - Mayo Clinic

    Patients who have received infliximab, adalimumab or certolizumab pegol ≤ 8 weeks before the first administration of study drug; Patients with certain ...

  2. Terbinafine (Oral Route) Precautions - Mayo Clinic

    This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.

  3. Antifibrotics may extend lives for patients with IPF - Mayo Clinic News Network

    Mayo Clinic researchers recently learned that patients who are taking antifibrotic drugs for idiopathic pulmonary fibrosis (IPF) have a better chance of ...

  4. What Patients and Doctors Should Know About Graves' Disease

    There are three treatment options for Graves' disease: anti-thyroid medication, radioactive iodine or surgery. These all reduce or eliminate thyroid hormone ...

  5. Cellular Therapy Clinical Trials - Mayo Clinic Research

    ... anti-Crohn's therapy. Six weeks post placement of the draining seton, the seton will be replaced with the MSC loaded Gore® Bio-A® fistula plug as per ...

  6. Teriflunomide (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  7. A Study to Evaluate LOXO-305 Vs. Approved BTK Inhibitor Approved Drugs to Treat Patients with Mantle Cell Lymphoma - Mayo Clinic

    A Study to Evaluate LOXO-305 Vs. Approved BTK Inhibitor Approved Drugs to Treat Patients with Mantle Cell Lymphoma. Print details. Share ...

  8. High cholesterol - Diagnosis and treatment - Mayo Clinic

    A blood test to check cholesterol levels — called a lipid panel or lipid profile — typically reports: Total cholesterol; LDL cholesterol; HDL cholesterol ...

  9. Darunavir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide (Oral Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Symtuza. Descriptions. Darunavir, cobicistat ...

  10. Exenatide (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Bydureon; BYDUREON BCise; Byetta. Descriptions.